Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2025)

Krystal Biotech's Exchange Rate Effect history spans 4 years, with the latest figure at -$637000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 7.24% year-over-year to -$637000.0; the TTM value through Dec 2025 reached $286000.0, up 162.45%, while the annual FY2025 figure was $286000.0, 162.45% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$637000.0 at Krystal Biotech, down from -$307000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.1 million in Q2 2025 and bottomed at -$637000.0 in Q4 2025.
  • The 4-year median for Exchange Rate Effect is -$36000.0 (2023), against an average of -$28384.6.
  • The largest YoY upside for Exchange Rate Effect was 2283.33% in 2024 against a maximum downside of 4312.5% in 2024.
  • A 4-year view of Exchange Rate Effect shows it stood at -$41000.0 in 2022, then tumbled by 241.46% to -$140000.0 in 2023, then plummeted by 324.29% to -$594000.0 in 2024, then dropped by 7.24% to -$637000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Exchange Rate Effect are -$637000.0 (Q4 2025), -$307000.0 (Q3 2025), and $1.1 million (Q2 2025).